Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study
Novartis
Novartis
University of Florida
Brigham and Women's Hospital
Murdoch Childrens Research Institute
Centre Hospitalier Régional d'Orléans
AstraZeneca
University Health Network, Toronto
University Health Network, Toronto
Tanta University
University of Wisconsin, Madison
Chongqing University Cancer Hospital
Brigham and Women's Hospital
Air Liquide Santé International
GT Medical Technologies, Inc.
Ottawa Hospital Research Institute
Isala
GT Medical Technologies, Inc.
University Hospital, Strasbourg, France
Kyoto University, Graduate School of Medicine
University Health Network, Toronto
VA Greater Los Angeles Healthcare System
Amsterdam UMC, location VUmc
University of Kentucky
Region Jönköping County
RECORDATI GROUP
Erasmus Medical Center
Chang Gung Memorial Hospital
Centre Hospitalier Universitaire Vaudois
Hospital Sirio-Libanes
University Medical Center Groningen
Pfizer
Jules Bordet Institute
Kyoto University, Graduate School of Medicine
Mayo Clinic
Danone Specialized Nutrition
University of Sao Paulo
Birmingham Women's and Children's NHS Foundation Trust
Xinjiang Medical University
Oregon Health and Science University
Gruppo Oncologico Italiano di Ricerca Clinica
Oslo University Hospital
Nova Scotia Health Authority
Altamash Institute of Dental Medicine
The University of Hong Kong
Azienda Ospedaliera Universitaria Integrata Verona
Hoffmann-La Roche
Germans Trias i Pujol Hospital
Peter MacCallum Cancer Centre, Australia
McMaster University
Hong Kong Children's Hospital